Skip to main content

Delhi High Court exercising its inherent powers passes summary judgment under the Commercial Courts Act in a trademark infringement suit. And in the process paves way for novel evidentiary proof to facilitate justice.

Galderma (Plaintiff) has used the CETAPHIL trade mark internationally since 1950 in relation to a range of skin care products, which were introduced in India in 2001. In addition to this mark, its products bear a unique trade dress with a distinct layout, get up et al. In conjunction, the plaintiff also employs the ‘Ellipses Device’, a very distinctive feature in and of itself.

It filed a suit in the Delhi High Court to restrain the defendant’s use of the mark CETAVEL for skin care products . The mark had been objected to by the Registrar of Trade Marks for its similarity to the plaintiff’s CETAPHIL mark. Moreover, the defendant’s products were sold in a similar packaging and displayed a virtually identical trade dress which even included a reproduction of the ‘Ellipses Device’.

The court was of the view that the plaintiff was entitled to a decree under Order XIII-A of the Commercial Courts, Commercial Division and Commercial Appellate Division of the High Courts Act, 2015. The provision empowers the court to pass a summary judgment, without recording evidence, if it appears that the defendant has no real prospect of defending the claim.

Pictures of third party skin care products submitted by the plaintiff demonstrated their packaging, get up, layout and more were distinct from CETAPHIL, unlike defendant’s bottle and mark. And the court noted that the defendant had not filed a written defence.

It concluded the defendant to have “slavishly imitated the plaintiff’s trade dress which demonstrates its mala fides.” A permanent injunction was granted against the defendant’s illegal use of Galderma’s CETAPHIL trade mark and the distinctive trade dress and elements.

The summary judgment under the Commercial Courts Act is a step in the right direction and demonstrates the Court’s inclination to speedy and expeditious disposal of cases, in particular those where there is no contest.

Galderma S.A. v Velite Healthcare; before the Delhi High Court; summary judgment dated 31.7.2017

Most Recent

News & Insights

VIEW ALL
Thought Leadership
Apr 12, 2025

‘First Published by Managing IP‘ By: Achuthan Sreekumar Achuthan Sreekumar of Anand and Anand draws on a recent High Court of Delhi ruling

Life and death matter? The protection of well-known personal names in India
Thought Leadership
Mar 27, 2025

‘First published on Lexology’ By: Safir Anand and Abhishek Paliwal India, one of the world’s fastest-growing economies, is on track to become a

Company Name vs. Trademark: Essential Insights for Establishing Your Business Brand in India
Thought Leadership
Mar 19, 2025

‘First published on Chambers and Partners’ By: Safir Anand and Twinky Rampal Law and Practice  1. Trade Mark and Copyright Law  1.1 Governing

Chambers Trademarks & Copyright 2025 | Law & Practice
Thought Leadership
Mar 19, 2025

‘First published on Chambers and Partners’ By: Safir Anand Introduction The landscape of intellectual property in India is undergoing a significant

Chambers Trademarks & Copyright 2025 | Trends and Developments